Prostaglandins and other cyclooxygenase-dependent arachidonic acid metabolites and the kidney in liver disease
- 19 September 2003
- journal article
- review article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 72 (1-2) , 19-33
- https://doi.org/10.1016/s1098-8823(03)00075-3
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysisProceedings of the National Academy of Sciences, 1999
- Pharmacological analysis of cyclooxygenase-1 in inflammationProceedings of the National Academy of Sciences, 1998
- Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammationPublished by Elsevier ,1998
- CYCLOOXYGENASES 1 AND 2Annual Review of Pharmacology and Toxicology, 1998
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Prostaglandin endoperoxide synthases-1 and -2Journal of Lipid Mediators and Cell Signalling, 1995
- Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.Proceedings of the National Academy of Sciences, 1994
- Human cyclooxygenase-2 cDNA.Proceedings of the National Academy of Sciences, 1992
- Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.Proceedings of the National Academy of Sciences, 1991
- Epidemiology of NSAID-Related Gastrointestinal Side EffectsScandinavian Journal of Gastroenterology, 1989